[HTML][HTML] Circulating angiotensin-(1–7) Is reduced in Alzheimer's disease patients and correlates with white matter abnormalities: results from a pilot study

VT Ribeiro, TM Cordeiro, RS Filha, LG Perez… - Frontiers in …, 2021 - frontiersin.org
Introduction Alzheimer's disease (AD) is the leading cause of dementia worldwide. Despite
the extensive research, its pathophysiology remains largely unelucidated. Currently, more …

Circulating Angiotensin-(1–7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study

VT Ribeiro, R da Silva Filha, LG Perez… - Frontiers in …, 2021 - scholars.uthscsa.edu
Introduction: Alzheimer's disease (AD) is the leading cause of dementia worldwide. Despite
the extensive research, its pathophysiology remains largely unelucidated. Currently, more …

Circulating Angiotensin-(1–7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study

VT Ribeiro, TM e Cordeiro… - The Role of the …, 2021 - books.google.com
Methods: We evaluated patients with AD (n= 14) and aged-matched controls (n= 14).
Plasma Ang II and Ang-(1–7) were dosed using ELISA. Brain MRI was performed in a 3 …

Circulating Angiotensin-(1-7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study

VT Ribeiro, TME Cordeiro… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Alzheimer's disease (AD) is the leading cause of dementia worldwide. Despite
the extensive research, its pathophysiology remains largely unelucidated. Currently, more …

Circulating Angiotensin-(1-7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study.

VT Ribeiro, TME Cordeiro, RDS Filha… - Frontiers in …, 2021 - europepmc.org
Methods We evaluated patients with AD (n= 14) and aged-matched controls (n= 14). Plasma
Ang II and Ang-(1-7) were dosed using ELISA. Brain MRI was performed in a 3 Tesla scan …

[PDF][PDF] Circulating Angiotensin-(1–7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study

VT Ribeiro, TM e Cordeiro, R da Silva Filha, LG Perez… - researchgate.net
Methods: We evaluated patients with AD (n= 14) and aged-matched controls (n= 14).
Plasma Ang II and Ang-(1–7) were dosed using ELISA. Brain MRI was performed in a 3 …

Circulating Angiotensin-(1–7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study.

VT Ribeiro, RS Filha, LG Perez… - Frontiers in …, 2021 - search.ebscohost.com
Introduction: Alzheimer's disease (AD) is the leading cause of dementia worldwide. Despite
the extensive research, its pathophysiology remains largely unelucidated. Currently, more …

[HTML][HTML] Circulating Angiotensin-(1–7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study

VT Ribeiro, TM e Cordeiro, R da Silva Filha… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Methods We evaluated patients with AD (n= 14) and aged-matched controls (n= 14). Plasma
Ang II and Ang-(1–7) were dosed using ELISA. Brain MRI was performed in a 3 Tesla scan …

Circulating Angiotensin-(1-7) Is Reduced in Alzheimer's Disease Patients and Correlates With White Matter Abnormalities: Results From a Pilot Study.

VT Ribeiro, TME Cordeiro, RDS Filha… - Frontiers in …, 2021 - europepmc.org
Methods We evaluated patients with AD (n= 14) and aged-matched controls (n= 14). Plasma
Ang II and Ang-(1-7) were dosed using ELISA. Brain MRI was performed in a 3 Tesla scan …